# Womens Health Devices Market

> Women’s Health Devices Market Research Report: Size, Share, Trend Analysis By Applications (General Health and wellness, Cancers and Other Chronic Diseases, Reproductive Health, Pregnancy and Nursing Care, Pelvic and Uterine Healthcare, and Others), By End-user (Hospitals and Clinics, Home Healthcare, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.3%
- **2024:** $ 63.03 Billion
- **2025:** $ 68.26 Billion
- **2035:** $ 151.55 Billion
- **Key Players:** Companies such as Abbott Laboratories (US), Bayer AG (DE), Medtronic(US), Hologic Inc. (US), Philips Healthcare (NL), GE Healthcare (US), Johnson & Johnson (US), Stryker Corporation (US), Siemens Healthineers (DE) are some of the major participants in the global market.

**Report ID:** MRFR/HC/9744-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/womens-health-devices-market-11263

---

## Market Summary

## **Global Women’s Health Devices Market Overview**

As per MRFR analysis, the Women’s Health Devices Market Size was estimated at 63.03 (USD Billion) in 2024. The Women’s Health Devices Market Industry is expected to grow from 68.26 (USD Billion) in 2025 to 139.93 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 8.30% during the forecast period (2025 - 2034).

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Women’s Health Devices Market Trends**

**Increased awareness of Women's health issues and Rise in prevalence of diseases about women's health is driving the market growth**

Market CAGR for Women’s Health Devices is being driven by the Increased awareness of women's health issues and the rise in the prevalence of diseases in women's health. In the context of contemporary demographics, the global female population has witnessed a substantial increase in its proportion. Simultaneously, the healthcare infrastructure worldwide, particularly in emerging economies, is anticipated to undergo significant enhancements. These improvements in the overall healthcare landscape have also amplified awareness and sensitivity to women's health concerns. These favorable market dynamics are propelling the growth of the global women's health devices market in the projected period. 

Multiple research studies have highlighted a notable rise in the prevalence of women's health conditions over recent decades. To mitigate mortality rates among female patients grappling with critical illnesses, several governments have initiated programs to promote and safeguard women's health. For instance, in January 2022, the U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) unveiled the Health of Women Program Strategic Plan, a strategic move to advocate for and safeguard women's health.

The overall surge in the prevalence of women's health conditions can be attributed to various factors, including advancements in diagnostic technologies and an increased emphasis on preventive care. Notably, certain female-specific cancers, such as cervical cancer, can be effectively treated when detected early. For instance, data from the World Health Organization (WHO) in 2022 revealed that [cervical cancer](../../../reports/cervical-cancer-treatment-market-5834) ranks as the fourth most common cancer among women, with an estimated 604,000 new cases in 2020. This heightened prevalence of women's diseases has generated greater demand for a diverse array of women's health devices.

As a result, it is anticipated that throughout the projection period, demand for the Women’s Health Devices Market will increase due to the Increased awareness of Women's health issues and the Rise in the prevalence of diseases about women's health. Thus, driving the Women’s Health Devices Market revenue.

## **Women’s Health Devices Market Segment Insights**

### **Women’s Health Devices Market Application Insights**

The Women’s Health Devices Market segmentation, based on Application includes General Health and wellness, Cancers and other Chronic Diseases, [Reproductive](../../../reports/assisted-reproductive-technology-market-6359) Health, Pregnancy and nursing Care, Pelvic and uterine Healthcare, and Others. The cancers and other chronic diseases segment dominated the market, accounting for 58% of market revenue (27.9 Billion). The prevalence of chronic diseases, including cancer, cardiovascular ailments, and diabetes, is on the rise among women on a global scale. 

According to the World Health Organization (WHO), cancer alone stands as a prominent cause of mortality, accounting for nearly 10 million deaths in 2020, equating to approximately one in six deaths. Approximately one-third of these cancer-related deaths can be attributed to modifiable risk factors, including tobacco use, high body mass index, alcohol consumption, inadequate fruit and vegetable intake, and lack of physical activity. These escalating health challenges are strongly linked to modern lifestyles characterized by physical inactivity, unhealthy dietary habits, and exposure to environmental factors.

Consequently, the growing incidence of these chronic diseases necessitates the development and adoption of advanced diagnostic and treatment devices. This, in turn, drives the heightened demand for women's health devices designed to cater to the precise needs of detecting, managing, and treating chronic diseases.

### **Women’s Health Devices Market End-user Insights**

The Women’s Health Devices Market segmentation, based on End-user includes Hospitals & Clinics, Home Healthcare, and Others. The hospitals & clinics segment dominated the market, accounting for 58% of market revenue (27.9 Billion). The robust expansion of healthcare infrastructure, marked by the establishment of new hospitals, clinics, and medical facilities, plays a pivotal role in driving growth within this segment. As indicated in the 2022 Economic Survey, India significantly bolstered its public healthcare expenditure, reaching 2.1% of GDP in the fiscal year 2021-22, up from 1.8% in 2020-21 and 1.3% in 2019-20. 

The private hospital sector in India is a thriving market, with an estimated worth of INR 13.67 trillion in fiscal year 2023, projected to reach INR 26 trillion by fiscal year 2027, displaying an impressive compound annual growth rate (CAGR) of 18.6%. A significant aspect is the predominance of privately owned hospitals, constituting 58% of all healthcare institutions in the country, housing a substantial 81% of the medical practitioner workforce in India. 

The reliance on private hospitals for healthcare services is notable, with 70% of urban households and 63% of rural households turning to these institutions for their family's healthcare needs. With the proliferation of healthcare establishments that cater to specialized women's health services, there is an increasing demand for advanced women's health devices to support these healthcare facilities and enhance the quality of women's healthcare services provided.

**Figure 1: Women’s Health Devices Market, by End-user, 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Women’s Health Devices Market Regional Insights**

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. According to the CDC, 6 IN 10 Adults in the US have a chronic disease. Cardiovascular disease is responsible for one in three deaths - 859,000 people - in the United States. Heart disease and stroke are responsible for $216 billion in healthcare system costs and $147 billion in lost job productivity. 

The prevalence of chronic diseases affecting approximately 60% of the U.S. population has played a pivotal role in driving demand for women's health devices. Additionally, leading market players in the region have directed significant investments toward research and development, clinical trials, and the marketing of innovative healthcare devices. These strategic efforts are anticipated to create an additional surge in demand for women's health devices across the United States and Canada.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 2: WOMEN’S HEALTH DEVICES MARKET SHARE BY REGION 2022 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

Europe Women’s Health Devices Market accounts for the second-largest market share as Europe boasts a well-established healthcare system with a strong emphasis on women's health. The region allocates significant financial resources to support women's healthcare, including investments in cutting-edge medical technologies, diagnostic apparatus, and specialized treatments for women-centric medical conditions. 

According to Eurostat, the European Union's collective general government expenditure on healthcare in 2021 amounted to a substantial €1,179 billion, equivalent to 8.1% of the region's GDP. Notably, countries like Germany and France led the way by allocating more than 12% of their respective GDP to healthcare. Sweden, Austria, the Netherlands, and Belgium also committed more than 11% of their GDP to healthcare, reflecting the region's strong commitment to health-related expenditures. Further, the German Women’s Health Devices Market held the largest market share, and the UK Women’s Health Devices Market was the fastest-growing market in the European region

The Asia-Pacific Women’s Health Devices Market is expected to grow at the fastest CAGR from 2023 to 2032. The expansion of healthcare infrastructure in Asian nations, the rising incidence of women's health conditions, and the growing awareness of technologically advanced women's health devices are significant drivers propelling market growth in the region. A notable example of this trend is the Class III approval granted by China's National Medical Products Administration to Japanese diagnostics company Sysmex for its Lynoamp BC in vitro diagnostic reagent for breast cancer in January 2020.

Such noteworthy product approvals within the region, combined with an uptick in healthcare investments, are anticipated to make a substantial contribution to robust regional market growth. Moreover, China’s Women’s Health Devices Market held the largest market share, and the Indian Women’s Health Devices Market was the fastest-growing market in the Asia-Pacific region.

### **Women’s Health Devices Market Key Market Players & Competitive Insights**

Leading market players are investing heavily in research and development to expand their product lines, which will help the Women’s Health Devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Women’s Health Devices industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Women’s Health Devices industry to benefit clients and increase the market sector. In recent years, the Women’s Health Devices industry has offered some of the most significant advantages to the field of healthcare and the well-being of women. Major players in the Women’s Health Devices Market, including Coloplast A/S (Denmark), Hologic Inc. (U.S.), Boston Scientific Corporation (U.S.), ALLERGAN (AbbVie, Inc.) (U.S.), BD (Becton, Dickinson, and Company) (U.S.), F.

Hoffmann-La Roche Ltd (Switzerland), CooperSurgical Inc. (The Cooper Companies, Inc.) (U.S.), Caldera Medical (U.S.), Reckitt Benckiser Group PLC (U.K.) are attempting to increase market demand by investing in research and development operations.

Coloplast A/S is a leading manufacturer and provider of a wide range of healthcare products and services. Their product portfolio covers ostomy care, respiratory solutions, urology care, continence care, and skin and wound care. This encompasses various essential items such as urisheaths, ostomy bags, catheters, anal irrigation systems, sling products, advanced dressings for wound care and skin protection, cleansers, moisturizers, skin protectants, anti-fungal products, and hand cleansers. The company markets its products under multiple brand names, including SenSura, SpeediCath, Persiteen, Biatain, Conveen, InterDry, Brava, and Comfeel.

Coloplast distributes its products through subsidiary companies and a network of distributors, reaching healthcare facilities, wholesalers, retailers, and institutions across Europe, Africa, South America, the UAE, Singapore, Asia, Russia, Australia, and North America. Coloplast's headquarters are situated in Humlebaek, Denmark.

Hoffmann-La Roche Ltd is a prominent biotechnology firm specializing in the development of drugs and diagnostic solutions for the treatment of major diseases. The company's extensive product portfolio includes medications for cancer treatment, various auto-immune conditions, central nervous system disorders, ophthalmological issues, infectious diseases, and respiratory ailments. Additionally, Roche offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche is dedicated to research aimed at discovering innovative approaches to disease prevention, diagnosis, and treatment. Its products and services are made available to a diverse clientele, including hospitals, healthcare professionals, commercial laboratories, researchers, and pharmacists.

The company operates in numerous countries worldwide, in collaboration with its subsidiaries and partners. Roche is headquartered in Basel, Switzerland. In December 2021, the company introduced the PIK3CA Mutation Test, serving breast cancer patients in regions where the CE mark is recognized, thereby offering a valuable diagnostic option.

**Key Companies in the Women’s Health Devices Market Include**

### Womens Health Devices Market Industry Developments

- **Q2 2024: Maven Clinic raises $90M Series E to expand women’s and family health platform** Maven Clinic, a digital health company focused on women’s and family health, secured $90 million in Series E funding to expand its virtual care offerings and global reach.
- **Q2 2024: Hologic receives FDA approval for new Genius Digital Diagnostics System** Hologic announced it received FDA approval for its Genius Digital Diagnostics System, a new device designed to improve cervical cancer screening for women in the United States.
- **Q2 2024: Clue secures $20 million in funding to advance menstrual health tracking technology** Berlin-based femtech company Clue raised $20 million in a new funding round to further develop its menstrual health tracking app and expand its product offerings.
- **Q2 2024: CooperSurgical acquires Ostro for undisclosed sum to bolster fertility solutions portfolio** CooperSurgical announced the acquisition of Ostro, a digital health company specializing in fertility support tools, to enhance its suite of women’s health and fertility solutions.
- **Q2 2024: Elvie launches Elvie Stride Plus, a new wearable breast pump in the US** Elvie, a leading femtech company, launched the Elvie Stride Plus, a wearable breast pump designed for hands-free, discreet pumping, expanding its product line in the US market.
- **Q3 2024: Theramex receives European Commission approval for Bijuva, a hormone therapy for menopause** Theramex announced it received European Commission approval for Bijuva, an oral hormone therapy for the treatment of menopause symptoms in women.
- **Q3 2024: Flo Health appoints new CEO to drive next phase of growth** Flo Health, the developer of a leading women’s health app, announced the appointment of a new CEO to lead the company’s global expansion and product innovation strategy.
- **Q3 2024: Natural Cycles partners with Oura to integrate temperature data for fertility tracking** Natural Cycles, a digital birth control app, announced a partnership with Oura to integrate temperature data from the Oura Ring, enhancing the app’s fertility tracking capabilities.
- **Q3 2024: Kindbody opens new fertility clinic in Chicago** Kindbody, a fertility and women’s health company, opened a new clinic in Chicago to expand access to fertility services and reproductive care.
- **Q4 2024: Ava Science receives FDA clearance for Ava Fertility Tracker 2.0** Ava Science announced it received FDA clearance for its updated Ava Fertility Tracker 2.0, a wearable device designed to help women track ovulation and improve chances of conception.
- **Q1 2025: FemTec Health raises $50 million in Series B funding to expand personalized women’s health platform** FemTec Health, a digital health startup focused on personalized women’s health solutions, raised $50 million in Series B funding to accelerate product development and market expansion.
- **Q2 2025: Roche launches new HPV self-sampling solution for cervical cancer screening** Roche announced the launch of a new HPV self-sampling solution, enabling women to collect samples at home for cervical cancer screening, aiming to increase screening rates and early detection.

## **Women’s Health Devices Market Segmentation**

### **Women’s Health Devices Market Application Outlook**

### **Women’s Health Devices Market End-user Outlook**

### **Women’s Health Devices Market Regional Outlook**

## Market Drivers

### Rising Awareness of Women's Health Issues

The increasing awareness surrounding women's health issues is a notable driver in the Global Women’s Health Devices Market Industry. As educational initiatives and health campaigns proliferate, women are becoming more informed about their health needs, leading to a higher demand for specialized health devices. This trend is reflected in the market's projected growth, with an estimated value of 63.0 USD Billion in 2024. The emphasis on preventive care and early diagnosis is likely to further stimulate the adoption of devices such as fertility monitors and menstrual health trackers, thereby enhancing overall health outcomes for women globally.

## Future Outlook

The Women’s Health Devices Market size is projected to reach USD 151.55 Billion by 2035, growing at a CAGR of 8.3%, driven by technological advancements, increasing awareness, and rising healthcare expenditures.

**New opportunities:**

- Development of telehealth platforms for remote monitoring of women's health Integration of AI-driven analytics in diagnostic devices Expansion of subscription-based models for health monitoring devices

By 2035, the market is expected to be robust, driven by innovation and increased consumer engagement.

## Segment Insights

### By Application: Fertility Monitoring (Largest) vs. Menopause Management (Fastest-Growing)

In the Women's Health Devices Market, the application segments showcase varied dominance. Fertility monitoring accounts for the largest 62% share among these segments, driven by growing awareness of reproductive health and the rising emphasis on effective family planning. This segment's prominence is further supported by technological advancements in fertility tracking, allowing women to understand their cycles better. On the other hand, Menopause Management is emerging swiftly as a notable segment, reflecting a growing awareness of menopausal health and the introduction of innovative products designed to ease symptoms associated with menopause. As the market evolves, several factors are driving growth within these segments. The surge in fertility awareness, coupled with rising disposable incomes, has amplified interest in Fertility Monitoring devices. Meanwhile, demographic shifts, including an aging population, are propelling the demand for Menopause Management solutions. Furthermore, educational campaigns and healthcare provider initiatives enhance accessibility and acceptance, positioning these segments for significant growth in the coming years.

Fertility Monitoring: Dominant vs. Menopause Management: Emerging

Fertility Monitoring is characterized by its advanced technological offerings, providing women with tools that range from ovulation detectors to hormone level analyzers. As the dominant application in the Women’s Health Devices Market, it empowers women by facilitating data-driven insights into their reproductive health. The implications of such technologies extend beyond simple monitoring; they play a crucial role in family planning and enhancing fertility awareness. Conversely, Menopause Management is rapidly becoming an emerging segment, largely due to the introduction of innovative relief solutions such as smart wearables and hormone therapy devices. This growing segment caters specifically to the needs of women experiencing menopausal transitions, bringing comfort and improved quality of life, and it is supported by increasing investment in research and relevant healthcare initiatives.

### By Device Type: Wearable Devices (Largest) vs. Diagnostic Devices (Fastest-Growing)

The Women’s Health Devices Market features a diverse range of device types, with wearable devices leading at a 66% share, driven by their growing popularity, convenience, and user-friendly functionality. These devices enable women to track their health metrics conveniently and in real-time, enhancing overall health management. Diagnostic devices, on the other hand, are seeing rapid growth as awareness of women's health issues and the importance of early diagnosis increases, making them an integral part of personal healthcare.

Wearable Devices (Dominant) vs. Diagnostic Devices (Emerging)

Wearable devices have established themselves as a dominant player in the Women's Health Devices Market by providing convenience and real-time health monitoring features. They empower women by allowing them to track their fitness levels, menstrual cycles, and overall well-being effortlessly. Conversely, diagnostic devices are emerging significantly, driven by technological advancements that enhance accuracy and ease of use. These devices are essential for early detection and monitoring of various health conditions, catering to the growing demand for personalized healthcare solutions. The interplay between these segments illustrates a dynamic market landscape where innovation and consumer needs shape the future.

### By End User: Healthcare Providers (Largest) vs. Hospitals (Fastest-Growing)

In the Women’s Health Devices Market, end-user segmentation shows that healthcare providers hold the largest 57% share, driven by their central role in delivering comprehensive women’s health services. Clinics and research institutions also contribute significantly, albeit to a lesser extent, while hospitals are emerging as a key factor in market dynamics. This structure indicates that healthcare providers and hospitals are at the forefront of shaping market trends, driving adoption, and influencing purchasing decisions.

Healthcare Providers (Dominant) vs. Hospitals (Emerging)

Healthcare providers are the dominant end users in the Women's Health Devices Market, as they not only facilitate access to essential health technology but also guide treatment protocols and innovations. Their established relationships with manufacturers enable streamlined procurement and adoption of new devices. Hospitals, on the other hand, are categorized as emerging players in this space, increasingly investing in advanced women's health solutions. This growth is driven by heightened awareness of women's health issues and the integration of technology to enhance patient care. The collaboration between hospitals and healthcare providers further strengthens the market landscape.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America is poised to maintain its leadership in the Women's Health Devices Market, holding a significant market share of 51% as of 2024. The region's growth is driven by increasing awareness of women's health issues, technological advancements, and supportive regulatory frameworks. The demand for innovative devices, such as diagnostic tools and treatment solutions, is on the rise, fueled by a growing emphasis on preventive healthcare and personalized medicine.

The competitive landscape in North America is robust, featuring key players like Abbott Laboratories, Medtronic, and Hologic Inc. These companies are at the forefront of developing cutting-edge technologies that cater to women's health needs. The U.S. remains the largest market, supported by a strong healthcare infrastructure and significant investments in research and development. The presence of major corporations ensures a continuous flow of innovation and improved healthcare outcomes for women.

### Europe : Emerging Regulatory Frameworks

Europe Women’s Health Devices Market accounted for 18% share in 2024, generating around USD 11.345 billion, making it a key regional market. The region benefits from evolving regulatory frameworks that promote innovation and ensure safety in women's health technologies. Increased government initiatives aimed at improving women's health services and rising awareness about health issues are key drivers of market growth. The demand for advanced diagnostic and therapeutic devices is expected to rise as healthcare policies increasingly focus on women's health.

Leading countries in this region include Germany, France, and the UK, where major players like Bayer AG and Siemens Healthineers are actively engaged in the market. The competitive landscape is characterized by a mix of established companies and emerging startups, fostering innovation. The European market is also witnessing collaborations between public and private sectors to enhance healthcare delivery, ensuring that women's health needs are adequately addressed.

### Asia-Pacific : Rapidly Growing Market Potential

The Asia-Pacific region is witnessing a burgeoning Women's Health Devices Market, currently valued at 10.0%. Factors such as increasing healthcare expenditure, rising awareness of women's health issues, and a growing aging population are driving this growth. Additionally, government initiatives aimed at enhancing healthcare access and quality are catalyzing demand for innovative health devices tailored for women. The region's diverse demographics present unique opportunities for market expansion.

Countries like China, India, and Japan are leading the charge in this market, with significant investments from key players such as Philips Healthcare and GE Healthcare. The competitive landscape is evolving, with both multinational corporations and local firms striving to capture market share. The increasing focus on women's health in public health policies is expected to further boost the market, making Asia-Pacific a key player in the global landscape.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region, with a market size of 3.03%, is gradually recognizing the importance of women's health devices. The growth in this region is driven by increasing awareness of women's health issues, coupled with government initiatives aimed at improving healthcare infrastructure. The demand for women's health devices is expected to rise as more women gain access to healthcare services and education about health issues increases.

Countries like South Africa and the UAE are leading the way in adopting innovative health solutions. The competitive landscape is characterized by a mix of local and international players, with companies exploring partnerships to enhance their market presence. As healthcare policies evolve to prioritize women's health, the region is poised for significant growth in the coming years.

## Competitive Benchmarking

The Womens Health Devices Market is currently characterized by a dynamic competitive landscape, driven by innovation, technological advancements, and a growing emphasis on personalized healthcare solutions. Key players such as Abbott Laboratories (US), Hologic Inc. (US), and Siemens Healthineers (DE) are strategically positioning themselves through a combination of product innovation and strategic partnerships.
 
These companies are focusing on enhancing their product portfolios to address the diverse needs of women's health, which includes reproductive health, diagnostics, and chronic disease management. Their collective strategies are shaping a competitive environment that is increasingly focused on delivering tailored solutions to improve patient outcomes.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs.
 
The market structure appears moderately fragmented, with several key players holding substantial market shares while also facing competition from emerging companies. This fragmentation allows for a variety of innovative solutions to emerge, as companies strive to differentiate themselves through unique offerings and improved service delivery.
 
In November Hologic Inc. (US) announced the launch of a new digital health platform aimed at enhancing the accessibility of women's health services. This platform integrates telehealth capabilities with traditional diagnostic tools, allowing for a more comprehensive approach to patient care. The strategic importance of this move lies in Hologic's commitment to leveraging technology to improve patient engagement and streamline healthcare delivery, which is increasingly vital in today's health landscape.
 
In October Siemens Healthineers (DE) expanded its partnership with a leading telemedicine provider to enhance remote monitoring capabilities for women's health. This collaboration aims to integrate advanced imaging technologies with telehealth services, thereby facilitating timely interventions and improving patient outcomes. The significance of this partnership is underscored by the growing demand for remote healthcare solutions, particularly in the context of women's health, where timely access to care can be critical.
 
In September Abbott Laboratories (US) unveiled a new line of wearable health monitoring devices specifically designed for women. These devices track various health metrics, including menstrual cycles and hormonal changes, providing users with personalized insights. This strategic initiative reflects Abbott's focus on innovation and its commitment to addressing the unique health needs of women, potentially positioning the company as a leader in this niche market.
 
As of December the competitive trends within the Womens Health Devices Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are playing a crucial role in shaping the current landscape, as companies collaborate to enhance their technological capabilities and expand their market reach. Looking ahead, it is likely that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains, as companies seek to meet the growing demand for personalized and efficient healthcare solutions.

## Recent News & Developments

- **Q2 2024: Maven Clinic raises $90M Series E to expand women’s and family health platform** Maven Clinic, a digital health company focused on women’s and family health, secured $90 million in Series E funding to expand its virtual care offerings and global reach.
- **Q2 2024: Hologic receives FDA approval for new Genius Digital Diagnostics System** Hologic announced it received FDA approval for its Genius Digital Diagnostics System, a new device designed to improve cervical cancer screening for women in the United States.
- **Q2 2024: Clue secures $20 million in funding to advance menstrual health tracking technology** Berlin-based [femtech](https://www.marketresearchfuture.com/reports/femtech-market-42230)company Clue raised $20 million in a new funding round to further develop its menstrual health tracking app and expand its product offerings.
- **Q2 2024: CooperSurgical acquires Ostro for undisclosed sum to bolster fertility solutions portfolio** CooperSurgical announced the acquisition of Ostro, a digital health company specializing in fertility support tools, to enhance its suite of women’s health and fertility solutions.
- **Q2 2024: Elvie launches Elvie Stride Plus, a new wearable breast pump in the US** Elvie, a leading femtech company, launched the Elvie Stride Plus, a wearable breast pump designed for hands-free, discreet pumping, expanding its product line in the US market.
- **Q3 2024: Theramex receives European Commission approval for Bijuva, a hormone therapy for menopause** Theramex announced it received European Commission approval for Bijuva, an oral hormone therapy for the treatment of menopause symptoms in women.
- **Q3 2024: Flo Health appoints new CEO to drive next phase of growth** Flo Health, the developer of a leading women’s health app, announced the appointment of a new CEO to lead the company’s global expansion and product innovation strategy.
- **Q3 2024: Natural Cycles partners with Oura to integrate temperature data for fertility tracking** Natural Cycles, a digital birth control app, announced a partnership with Oura to integrate temperature data from the Oura Ring, enhancing the app’s fertility tracking capabilities.
- **Q3 2024: Kindbody opens new fertility clinic in Chicago** Kindbody, a fertility and women’s health company, opened a new clinic in Chicago to expand access to [fertility services](https://www.marketresearchfuture.com/reports/fertility-services-market-6281) and reproductive care.
- **Q4 2024: Ava Science receives FDA clearance for Ava Fertility Tracker 2.0** Ava Science announced it received FDA clearance for its updated Ava Fertility Tracker 2.0, a wearable device designed to help women track ovulation and improve chances of conception.
- **Q1 2025: FemTec Health raises $50 million in Series B funding to expand personalized women’s health platform** FemTec Health, a digital health startup focused on personalized women’s health solutions, raised $50 million in Series B funding to accelerate product development and market expansion.
- **Q2 2025: Roche launches new HPV self-sampling solution for cervical cancer screening** Roche announced the launch of a new HPV self-sampling solution, enabling women to collect samples at home for cervical cancer screening, aiming to increase screening rates and early detection.

## Report Scope

| MARKET SIZE 2024 | 63.03(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 68.26(USD Billion) |
| MARKET SIZE 2035 | 151.55(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.3% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Abbott Laboratories (US), Bayer AG (DE), Medtronic (US), Hologic Inc. (US), Philips Healthcare (NL), GE Healthcare (US), Johnson & Johnson (US), Stryker Corporation (US), Siemens Healthineers (DE) |
| Segments Covered | Application, Device Type, End User |
| Key Market Opportunities | Integration of wearable technology enhances monitoring and management of women's health conditions. |
| Key Market Dynamics | Rising consumer awareness drives demand for innovative women's health devices amid evolving regulatory and technological landscapes. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Women's Health Devices Market by 2035?**
A: The market is projected to reach a valuation of 151.55 USD Billion by 2035.

**Q: What was the market valuation of the market in 2024?**
A: In 2024, the market was valued at 63.03 USD Billion.

**Q: What is the expected CAGR for the Women's Health Devices Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during the forecast period 2025 - 2035 is 8.3%.

**Q: Which segments are included in the Women's Health Devices Market by application?**
A: The segments by application include Fertility Monitoring, Menstrual Health, Pregnancy Care, Menopause Management, and Sexual Health.

**Q: What are the projected valuations for the Fertility Monitoring segment by 2035?**
A: The Fertility Monitoring segment is projected to reach a valuation of 19.0 USD Billion by 2035.

**Q: Who are the key players in the Women's Health Devices Market?**
A: Key players in the market include Abbott, Bayer, Medtronic, Hologic, Philips, GE Healthcare, Johnson & Johnson, Stryker, and Siemens Healthineers.

**Q: What is the projected market size for the Surgical Devices segment by 2035?**
A: The Surgical Devices segment is projected to reach a market size of 26.55 USD Billion by 2035.

**Q: What are the projected valuations for the Monitoring Devices segment by 2035?**
A: The Monitoring Devices segment is projected to reach a valuation of 35.0 USD Billion by 2035.

**Q: Which end users are included in the Women's Health Devices Market?**
A: End users in the market include Individuals, Healthcare Providers, Clinics, Hospitals, and Research Institutions.

**Q: What is the projected market size for the Hospitals segment by 2035?**
A: The Hospitals segment is projected to reach a market size of 40.0 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/womens-health-devices-market-11263*